Cathleen J. Park
Hematology | Oncology
101 The City Drive South
Building 23
Orange, CA 92868
Building 23
Orange, CA 92868
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.
Journal: Cancer treatment reviews
Published: June 07, 2026
Consideration of Enrollment Rates of Asian, Asian Pacific Islander, and Hispanic Patients in Non-small Cell Lung Cancer Trials.
Journal: Targeted oncology
Published: April 30, 2026
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case Report.
Journal: Lung Cancer (Auckland, N.Z.)
Published: February 09, 2026
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report.
Journal: Lung Cancer (Auckland, N.Z.)
Published: June 23, 2025
Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib.
Journal: Lung Cancer (Auckland, N.Z.)
Published: June 14, 2025
The development of Zongertinib for HER2-mutant NSCLC.
Journal: Critical reviews in oncology/hematology
Published: May 18, 2025
MET Tyrosine Kinase Domain Mutations in NSCLC: Expanding the Landscape of Acquired Resistance in Oncogene-Driven Tumors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 02, 2025
Old Wine in New Bottles? Deuterium Switch (Replacing Hydrogen With Deuterium) Comes to Thoracic Oncology as Deuterated Lorlatinib (Deulorlatinib, TGRX-326) and Deuterated Osimertinib (Asandeutertinib, TY-9591) in ALK+ NSCLC and EGFR+ NSCLC, Respectively.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 14, 2025
Advancing the Needle on the Management of Resectable EGFR-Positive NSCLC: Is Neoadjuvant Osimertinib the Answer?
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 04, 2025
ALK Tyrosine Kinase Inhibitors Induced Weight Gain: More Refined Definition of Weight Gain, Glucagon-Like Peptide-1 Agonist Treatment, and Therapeutic Drug Monitoring of ALK+ Non-Small Cell Lung Cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2025
Correction: Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats.
Journal: PLoS neglected tropical diseases
Published: April 11, 2015
Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats.
Journal: PLoS neglected tropical diseases
Published: October 13, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026